187 related articles for article (PubMed ID: 1741252)
1. Biophysical analysis of DNA modified by 1,2-diaminocyclohexane platinum(II) complexes.
Boudný V; Vrána O; Gaucheron F; Kleinwachter V; Leng M; Brabec V
Nucleic Acids Res; 1992 Jan; 20(2):267-72. PubMed ID: 1741252
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against (1R,2R)-cyclohexanediamineplatinum(II)-DNA adduct recognize the conformational differences of isomeric analogues of cyclohexanediamine.
Yamada H; Kato T; Hirose J; Inagaki K; Noji M; Kidani Y
Biochim Biophys Acta; 1990 Jul; 1049(3):298-302. PubMed ID: 2383586
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
4. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand.
Yamashita T; Hirose J; Noji M; Saito R; Tomida H; Kidani Y
Biol Pharm Bull; 1993 Oct; 16(10):1014-8. PubMed ID: 8287030
[TBL] [Abstract][Full Text] [Related]
6. 2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex.
Spingler B; Whittington DA; Lippard SJ
Inorg Chem; 2001 Oct; 40(22):5596-602. PubMed ID: 11599959
[TBL] [Abstract][Full Text] [Related]
7. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the reactivity of oxaliplatin, pt(diaminocyclohexane)Cl2 and pt(diaminocyclohexane1)(OH2)2(2+) with guanosine and L-methionine.
Verstraete S; Heudi O; Cailleux A; Allain P
J Inorg Biochem; 2001 Mar; 84(1-2):129-35. PubMed ID: 11330471
[TBL] [Abstract][Full Text] [Related]
9. Anticancer activity of new imidazole derivative of 1R,2R-diaminocyclohexane palladium and platinum complexes as DNA fluorescent probes.
Hadian Rasanani S; Eslami Moghadam M; Soleimani E; Divsalar A; Ajloo D; Tarlani A; Amiri M
J Biomol Struct Dyn; 2018 Sep; 36(12):3058-3076. PubMed ID: 29027501
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of isomeric 1,2-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
J Cancer Res Clin Oncol; 1994; 120(7):409-14. PubMed ID: 8188734
[TBL] [Abstract][Full Text] [Related]
11. Antitumor platinum(II) complexes of N-monoalkyl 1R,2R-diamino-cyclohexanes with 3-(nitrooxy)cyclobutane-1,1-dicarboxylate as a leaving group.
Zhao J; Gou S; Xu G; Cheng L
Eur J Med Chem; 2014 Oct; 85():408-17. PubMed ID: 25108080
[TBL] [Abstract][Full Text] [Related]
12. Platinum-DNA interstrand crosslinks: molecular determinants of bending and unwinding of the double helix.
Suchánková T; Kubíček K; Kašpárková J; Brabec V; Kozelka J
J Inorg Biochem; 2012 Mar; 108():69-79. PubMed ID: 22019433
[TBL] [Abstract][Full Text] [Related]
13. Combining the platinum(ii) drug candidate kiteplatin with 1,10-phenanthroline analogues.
Pages BJ; Sakoff J; Gilbert J; Zhang Y; Kelly SM; Hoeschele JD; Aldrich-Wright JR
Dalton Trans; 2018 Feb; 47(7):2156-2163. PubMed ID: 29192713
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers.
Pendyala L; Kidani Y; Perez R; Wilkes J; Bernacki RJ; Creaven PJ
Cancer Lett; 1995 Nov; 97(2):177-84. PubMed ID: 7497460
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring Pt II chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand.
Kasparkova J; Suchankova T; Halamikova A; Zerzankova L; Vrana O; Margiotta N; Natile G; Brabec V
Biochem Pharmacol; 2010 Feb; 79(4):552-64. PubMed ID: 19782655
[TBL] [Abstract][Full Text] [Related]
16. Photoactive platinum(II) complexes of nonsteroidal anti-inflammatory drug naproxen: Interaction with biological targets, antioxidant activity and cytotoxicity.
Srivastava P; Singh K; Verma M; Sivakumar S; Patra AK
Eur J Med Chem; 2018 Jan; 144():243-254. PubMed ID: 29274491
[TBL] [Abstract][Full Text] [Related]
17. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
Yoshida M; Khokhar AR; Siddik ZH
Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
[TBL] [Abstract][Full Text] [Related]
18. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.
Lovejoy KS; Todd RC; Zhang S; McCormick MS; D'Aquino JA; Reardon JT; Sancar A; Giacomini KM; Lippard SJ
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):8902-7. PubMed ID: 18579768
[TBL] [Abstract][Full Text] [Related]
19. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes.
Khokhar AR; al-Baker S; Shamsuddin S; Siddik ZH
J Med Chem; 1997 Jan; 40(1):112-6. PubMed ID: 9016335
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
Kido Y; Khokhar AR; al-Baker S; Siddik ZH
Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
